Skip to main content
Top
Published in: Neurological Sciences 12/2016

01-12-2016 | Original Article

Association of VEGF gene polymorphisms with sporadic Parkinson’s disease in Chinese Han population

Authors: Yubin Wu, Yingying Zhang, Xun Han, Xiaoyuan Li, Li Xue, Anmu Xie

Published in: Neurological Sciences | Issue 12/2016

Login to get access

Abstract

Recent evidence indicates that vascular endothelial growth factor (VEGF) is capable of protecting dopaminergic (DA) neurons. Parkinson’s disease (PD) is a progressive neurodegenerative disease caused by the degeneration of nigrostriatal dopaminergic neurons. To evaluate the role of VEGF single nucleotide polymorphisms (SNPs) and haplotypes in PD, we performed a case–control study including 400 PD patients and 400 healthy-matched controls. Polymerase chain reaction-restriction fragment length polymorphism (PCR–RFLP) analysis and DNA sequencing were used to detect the rs699947, rs2010963 and rs3025039 polymorphisms of the VEGF gene in cases and controls. Our study revealed that T allelic frequency of rs3025039 polymorphism was significantly higher in PD subjects (OR 1.497, 95 % CI 1.099–2.040, P = 0.013) than that in controls. Significant association for rs3025039 could be found in additive model (TT vs. CT vs. CC: OR 1.489, 95 % CI 1.018–2.177, P = 0.040) and dominant model (TT + CT vs. CC: OR 1.538, 95 % CI 1.068–2.216, P = 0.021). Subgroup analyses performed by gender suggested that this association could be found in male, but not in female. Moreover, it also demonstrated a significant association in the subgroup of late-onset PD (LOPD). However, for rs699947 and rs2010963 polymorphisms, genotype or allele frequencies did not differ between groups. No significant association could be found between rs699947 and rs2010963 polymorphism and PD risk. None of the observed haplotypes showed significant association with PD. Therefore, these results suggested that the VEGF gene might be associated with risk of developing sporadic PD in Han Chinese and the rs3025039 polymorphism may be a risk factor for sporadic PD.
Literature
5.
go back to reference Quittet MS, Touzani O, Sindji L, Cayon J, Fillesoye F, Toutain J, Divoux D, Marteau L, Lecocq M, Roussel S, Montero-Menei CN, Bernaudin M (2015) Effects of mesenchymal stem cell therapy, in association with pharmacologically active microcarriers releasing VEGF, in an ischaemic stroke model in the rat. Acta Biomater 15:77–88. doi:10.1016/j.actbio.2014.12.017 CrossRefPubMed Quittet MS, Touzani O, Sindji L, Cayon J, Fillesoye F, Toutain J, Divoux D, Marteau L, Lecocq M, Roussel S, Montero-Menei CN, Bernaudin M (2015) Effects of mesenchymal stem cell therapy, in association with pharmacologically active microcarriers releasing VEGF, in an ischaemic stroke model in the rat. Acta Biomater 15:77–88. doi:10.​1016/​j.​actbio.​2014.​12.​017 CrossRefPubMed
8.
go back to reference Zachary I (2005) Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function, and therapeutic potential. Neuro-Signals 14(5):207–221. doi:10.1159/000088637 CrossRefPubMed Zachary I (2005) Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function, and therapeutic potential. Neuro-Signals 14(5):207–221. doi:10.​1159/​000088637 CrossRefPubMed
10.
11.
go back to reference Yasuhara T, Shingo T, Muraoka K, Wen Ji Y, Kameda M, Takeuchi A, Yano A, Nishio S, Matsui T, Miyoshi Y, Hamada H, Date I (2005) The differences between high and low-dose administration of VEGF to dopaminergic neurons of in vitro and in vivo Parkinson’s disease model. Brain Res 1038(1):1–10. doi:10.1016/j.brainres.2004.12.055 CrossRefPubMed Yasuhara T, Shingo T, Muraoka K, Wen Ji Y, Kameda M, Takeuchi A, Yano A, Nishio S, Matsui T, Miyoshi Y, Hamada H, Date I (2005) The differences between high and low-dose administration of VEGF to dopaminergic neurons of in vitro and in vivo Parkinson’s disease model. Brain Res 1038(1):1–10. doi:10.​1016/​j.​brainres.​2004.​12.​055 CrossRefPubMed
12.
go back to reference Yasuda T, Fukuda-Tani M, Nihira T, Wada K, Hattori N, Mizuno Y, Mochizuki H (2007) Correlation between levels of pigment epithelium-derived factor and vascular endothelial growth factor in the striatum of patients with Parkinson’s disease. Exp Neurol 206(2):308–317. doi:10.1016/j.expneurol.2007.05.012 CrossRefPubMed Yasuda T, Fukuda-Tani M, Nihira T, Wada K, Hattori N, Mizuno Y, Mochizuki H (2007) Correlation between levels of pigment epithelium-derived factor and vascular endothelial growth factor in the striatum of patients with Parkinson’s disease. Exp Neurol 206(2):308–317. doi:10.​1016/​j.​expneurol.​2007.​05.​012 CrossRefPubMed
14.
15.
go back to reference Samli H, Demir BC, Ozgoz A, Atalay MA, Uncu G (2012) Vascular endothelial growth factor gene 1154 G/A, 2578 C/A, 460 C/T, 936 C/T polymorphisms and association with recurrent pregnancy losses. Genet Mol Res: GMR 11(4):4739–4745. doi:10.4238/2012.December.17.6 CrossRefPubMed Samli H, Demir BC, Ozgoz A, Atalay MA, Uncu G (2012) Vascular endothelial growth factor gene 1154 G/A, 2578 C/A, 460 C/T, 936 C/T polymorphisms and association with recurrent pregnancy losses. Genet Mol Res: GMR 11(4):4739–4745. doi:10.​4238/​2012.​December.​17.​6 CrossRefPubMed
16.
go back to reference Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE (2000) Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 12(8):1232–1235. doi:10.1006/cyto.2000.0692 CrossRefPubMed Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE (2000) Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 12(8):1232–1235. doi:10.​1006/​cyto.​2000.​0692 CrossRefPubMed
17.
go back to reference Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, Wolf G, Wascher TC, Paulweber B, Haas J, Samonigg H (2003) A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer 106(4):468–471. doi:10.1002/ijc.11238 CrossRefPubMed Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, Wolf G, Wascher TC, Paulweber B, Haas J, Samonigg H (2003) A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer 106(4):468–471. doi:10.​1002/​ijc.​11238 CrossRefPubMed
18.
go back to reference Del Bo R, Scarlato M, Ghezzi S, Martinelli Boneschi F, Fenoglio C, Galbiati S, Virgilio R, Galimberti D, Galimberti G, Crimi M, Ferrarese C, Scarpini E, Bresolin N, Comi GP (2005) Vascular endothelial growth factor gene variability is associated with increased risk for AD. Ann Neurol 57(3):373–380. doi:10.1002/ana.20390 CrossRefPubMed Del Bo R, Scarlato M, Ghezzi S, Martinelli Boneschi F, Fenoglio C, Galbiati S, Virgilio R, Galimberti D, Galimberti G, Crimi M, Ferrarese C, Scarpini E, Bresolin N, Comi GP (2005) Vascular endothelial growth factor gene variability is associated with increased risk for AD. Ann Neurol 57(3):373–380. doi:10.​1002/​ana.​20390 CrossRefPubMed
21.
go back to reference Kim JS, Yim SV, Koh IS, Choi JS, Yoo JY, Lee KS, Lim Y, Lee KH (2009) Single-nucleotide polymorphisms (SNPs) and haplotype analysis in vascular endothelial growth factor (VEGF) gene in the patients with Parkinson disease and lung cancer. Arch Gerontol Geriatr 48(3):287–290. doi:10.1016/j.archger.2008.02.007 CrossRefPubMed Kim JS, Yim SV, Koh IS, Choi JS, Yoo JY, Lee KS, Lim Y, Lee KH (2009) Single-nucleotide polymorphisms (SNPs) and haplotype analysis in vascular endothelial growth factor (VEGF) gene in the patients with Parkinson disease and lung cancer. Arch Gerontol Geriatr 48(3):287–290. doi:10.​1016/​j.​archger.​2008.​02.​007 CrossRefPubMed
22.
25.
go back to reference Mateo I, Llorca J, Infante J, Rodriguez-Rodriguez E, Sanchez-Quintana C, Sanchez-Juan P, Berciano J, Combarros O (2006) Case–control study of vascular endothelial growth factor (VEGF) genetic variability in Alzheimer’s disease. Neurosci Lett 401(1–2):171–173. doi:10.1016/j.neulet.2006.03.020 CrossRefPubMed Mateo I, Llorca J, Infante J, Rodriguez-Rodriguez E, Sanchez-Quintana C, Sanchez-Juan P, Berciano J, Combarros O (2006) Case–control study of vascular endothelial growth factor (VEGF) genetic variability in Alzheimer’s disease. Neurosci Lett 401(1–2):171–173. doi:10.​1016/​j.​neulet.​2006.​03.​020 CrossRefPubMed
26.
go back to reference Vught PWV, Sutedja NA, Veldink JH, Koeleman BP, Groeneveld GJ, Wijmenga C, Uitdehaag BM, Jong JMD, Baas F, Wokke JH, Berg LHVD (2005) Lack of association between VEGF polymorphisms and ALS in a Dutch population. Neurology 22:1643–1645CrossRef Vught PWV, Sutedja NA, Veldink JH, Koeleman BP, Groeneveld GJ, Wijmenga C, Uitdehaag BM, Jong JMD, Baas F, Wokke JH, Berg LHVD (2005) Lack of association between VEGF polymorphisms and ALS in a Dutch population. Neurology 22:1643–1645CrossRef
Metadata
Title
Association of VEGF gene polymorphisms with sporadic Parkinson’s disease in Chinese Han population
Authors
Yubin Wu
Yingying Zhang
Xun Han
Xiaoyuan Li
Li Xue
Anmu Xie
Publication date
01-12-2016
Publisher
Springer Milan
Published in
Neurological Sciences / Issue 12/2016
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-016-2691-x

Other articles of this Issue 12/2016

Neurological Sciences 12/2016 Go to the issue